Trajectories of metabolic parameters after bilateral oophorectomy in premenopausal women

Objective: To study the trajectories of metabolic parameters after bilateral oophorectomy. Study design: This population-based cohort study included a random sample of all premenopausal women who underwent bilateral oophorectomy at or before age 45 years from 1988 to 2007 in Olmsted County, Minnesota, and their age-matched (& PLUSMN;1 year) referent women who did not undergo bilateral oophorectomy. Main outcome measures: The medical records of all women were reviewed to collect the metabolic parameters over a 10-year period. We compared three groups of women: 1) referent women (n = 270), 2) women who underwent bilateral oophorectomy and received estrogen therapy (n = 163), and 3) women who underwent bilateral oophorectomy and did not receive estrogen therapy (n = 107). Results: Over 10 years of follow-up, the three groups had significantly different mean values of diastolic blood pressure, weight, body mass index (BMI), total cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C). However, women with and without bilateral oophorectomy were already different at baseline for hyperlipidemia, systolic blood pressure, weight, and BMI. Nevertheless, the trajectories of change over 10 years were significant for weight (group by time interaction p = 0.03), BMI (p = 0.03), and HDL-C (p = 0.004). The changes occurred primarily in the initial 4-5 years. Women who received estrogen therapy after bilateral oo-phorectomy were comparable to the referent women with respect to the weight and BMI trends, and they experienced an increase in HDL-C over time. Conclusion: Women who underwent bilateral oophorectomy before menopause experienced unfavorable changes in some metabolic parameters possibly increasing their cardiovascular risk.

Automated summary

The study aimed to investigate the trajectories of metabolic parameters after bilateral oophorectomy. The results showed significant differences in weight, body mass index (BMI), and high-density lipoprotein cholesterol (HDL-C) among the three groups. Although there were baseline differences, the changes primarily occurred in the initial 4-5 years. Women who received estrogen therapy after bilateral oophorectomy had similar weight and BMI trends as the control group and experienced an increase in HDL-C over time.